Article Text


P5.064 Preliminary Analytical Evaluation of Artus® CT/NG, For Simultaneous Detection of Neisseria Gonorrhoeae and Chlamydia Trachomatis
  1. S N Tabrizi1,2,
  2. J Twin1,
  3. M Unemo3,
  4. A Wiezer4,
  5. A Limnios5,
  6. M Lahra5,
  7. S Garland1,6
  1. 1The Royal Women’s Hospital, Parkville, Australia
  2. 2Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Australia
  3. 3WHO Collaborating Centre for Gonorrhoea and other STIs, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden
  4. 4QIAGEN Research and Development, Hamburg, Germany
  5. 5WHO Collaborating Centre for STD, Microbiology Department, The Prince of UK Hospital, Randwick, Australia
  6. 62) Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Australia


Introduction Currently there are a number of molecular amplification assays for detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Prior to introduction of any new assay, it should be thoroughly evaluated for potential false positive and false negative results due to cross reaction with other species, and potential mutations and genetic exchanges with other closely related organisms. Artus® CT/NG is currently a research use only kit (with the fully automated version to be released later this year)for simultaneously detection of C. trachomatis and N. gonorrhoeae. We performed preliminary analytical evaluation of this assay.

Method This study evaluated the Artus® CT/NG assay with 290 characterised culture isolates obtained from the Neisseria Reference Laboratory at the World Health Organization Collaborating Centres for Sexually Transmitted Disease (STD) in Sydney and WHO Collaborating Centre for Gonorrhoea and other STIs in Örebro, Sweden. Strains included 148 N. gonorrhoeae isolates, 130 isolates of non-gonococcal Neisseria species, 12 isolates of other species closely related to Neisseria and 16 C. trachomatis strains of different serovars (including LGV and nvCT strains).

Results All C. trachomatis and N. gonorrhoeae isolates were detected. A detection sensitivity of 10 genome copies per reaction was obtained with all C. trachomatis serovars as well as a representative N. gonorrhoeae control strain. All 142 non-gonococcal isolates were negative on the assay.

Conclusion Overall, from this limited evaluation, Artus® CT/NG is analytically highly sensitive and specific for the detection of C. trachomatis and N. gonorrhoeae. Further assessment with clinical samples would need to be done to fully assess the performance of this assay prior to clinical implementation.

  • Chlamydia trachomatis
  • Neisseria gonorrhoeae

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.